Tweets
The current NEJM reports that the use of the Pfizer mRNA vaccine (BNT162b2) demonstrated a very low risk for certain serious adverse events, including the risk of myocarditis (1 to 5 events per 100,000 persons).
https://t.co/CT4dQK9XlH https://t.co/enddiHtX1G
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
1458 RA patients (74% seropositive) followed longitudinally for ROM & surgical outcomes. Seropositive and seronegative patients had loss of ROM over time (7–13%/Yr), and surgical needs. T2T approaches should be followed irrespective of RF status https://t.co/ohmDTLfP9S
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
85% relapse median 22 wks , 20% ISR, quickly regain MDA, why would you? https://t.co/VtQ3ClumBl
Peter Nash @drpnash ( View Tweet )
4 years 11 months ago
Can an anti-inflammatory diet impact axial spondyloarthritis (axSpA)? A 6-month dietary intervention shows that adherence to a Mediterranean diet lowers disease activity in axSpA; but dietary adherence is often incomplete.
https://t.co/AqtYO60XbH https://t.co/uYil2YvOR1
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
A current report in Arthritis & Rheumatology examined the Nurses Health Study II data set and shows that parental smoking, and passive exposure to children, can later lead to an increased risk of adult-onset incident seropositive RA.
https://t.co/szl5L7DGJG https://t.co/vAXBNPxsWU
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Arthritis clinic referrals divided into 2 cohorts: (A) 163 w/ MSK US before visit; (B) 109 without initial MSK US. MSK-US at 1st visit reduced time to Dx from mean 31 to 12 days (p< 0.01), # of clinic visits, & increased odds of inflamm Dx (47% vs 27%) https://t.co/FaXLBlRlxy
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Rheumatic Events With Checkpoint Inhibitors: Tumor Type Matters
https://t.co/vT6185ycoG https://t.co/G14eLN2JkT
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Si @DGlaucomflecken es el mejor se dice y ya está https://t.co/QzPyIe5gAA
Raruniente @Raruniiente ( View Tweet )
4 years 11 months ago
New podcast available for download!
COVID Marching Amidst the Madness
https://t.co/xYzkw3zGRt https://t.co/gv45nVk9v5
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
In case you missed it:
Biologic Therapy of Psoriasis May Prevent Psoriatic Arthritis
Another retrospective cohort study has shown that biologic treatment of psoriasis may reduce the subsequent incidence of psoriatic arthritis (PsA).
https://t.co/2YbLBsFedv https://t.co/OYMJ6Y54UF
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
ICYMI:
European Commission approves upadacitinib (Rinvoq)-first JAK Inhibitor for use in adults & adolescents with Moderate to Severe Atopic Dermatitis. UPA is approved for atopic dermatitis in other nations, Russia, Saudi Arabia; pending review in US https://t.co/hiPkJoJCex
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
ICYMI:
European Commission has approved tofacitinib (Xeljanz) to treat active polyarticular juvenile idiopathic arthritis & juvenile psoriatic arthritis (PsA) > 2yrs old, not responding to DMARDs (as tablet & new oral solution (weight-based dosing) https://t.co/FyqZI0qsYa
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
